Skip to content
zarza zarza
Advertisement

MARIPOSA

27/06/2024 10 min
MARIPOSA

Episode Synopsis

The MARIPOSA study suggests there may be a new preferred first line regimen (amivantamab + lazertinib) for metastatic EGFR-mutated NSCLC, as this regimen improved PFS compared to osimertinib.

ZARZA Studio — Your station on air today: library, music clock, schedule, studio and reports, from the browser.

Meet ZARZA Studio
on air now stations in the catalogue 1,829,025 podcasts countries